Picture of Genprex logo

GNPX — Genprex News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Genprex Inc expected to post a loss of 39 cents a share - Earnings Preview

Genprex Inc GNPX.OQ GNPX.O is expected to report results on March 31 (estimated) for the period ending December 31 2024

​LSEG's mean analyst estimate for Genprex Inc is for a loss of 39 cents per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Genprex Inc is $7.50​, above​ its last closing price of $0.34. ​​​

This summary was machine generated March 28 at 20:35 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Genprex

See all news